Exclusive

Publication

Byline

Pixelgen Technologies further expands Asia presence through distribution agreement with MDxK

Singapore, Dec. 16 -- Pixelgen Technologies, Inc. andMDxK (Molecular Diagnostics Korea) Inc., part of DKSH Business Unit Technology, a leader in market expansion services, have announced a distributio... Read More


Zuellig Pharma expands partnership with Lundbeck for commercialisation of neuro-psychiatric health solutions in Asia

Singapore, Dec. 16 -- Singapore-basedZuellig Pharma, a leading healthcare solutions company in Asia, has expanded its partnership with H. Lundbeck A/S, a biopharmaceutical company focusing exclusively... Read More


Japan's Olympus triples Venture Capital Fund investment to strengthen MedTech leadership

Singapore, Dec. 15 -- Japan-basedOlympus Corporationhas announced an additional commitment to its corporate venture capital fund, Olympus Innovation Ventures, LLC (OIV), with the launch of Olympus Inn... Read More


Korea marks milestone for blood-based Alzheimer's diagnostics ecosystem

Singapore, Dec. 15 -- Quanterix Corporation, a US.-based biotechnology company specialising in ultrasensitive biomarker detection, and its clinical diagnostics brand Lucent Diagnostics, together withE... Read More


UK and Singapore launch new regulatory innovation corridor to fast track health technologies

Singapore, Dec. 12 -- As part of this first-of-its-kind partnership between the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and Singapore's Health Sciences Authority (HSA), compani... Read More


Japan's Chugai establishes partnering office in US to accelerate global open innovation

Singapore, Dec. 12 -- Japan-based Chugai Pharmaceutical has announced the establishment of a new partnering office in South San Francisco, US. The office will operate as a branch of Chugai's wholly-ow... Read More


Eli Lilly to build $6 B worth API manufacturing facility in US

Singapore, Dec. 12 -- Eli Lilly and Company has announced a plan to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama.The site will focus on producing active pharmaceu... Read More


Chinese startup D3 Bio secures $108 M to advance global clinical programmes

Singapore, Dec. 12 -- D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, has announced the completion of a $108 million... Read More


Yao Pharma licenses oral GLP-1R agonists to Pfizer for $1.93 B

Singapore, Dec. 10 -- China's Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Shanghai Fosun Pharmaceutical Industrial Development Company Limited, and Pfizer Inc. ... Read More


Fapon andBio Farma partner to advance IVD localisation and innovation in Indonesia

Singapore, Dec. 9 -- PT Fapon Bioindustries Indonesia and the Indonesian state-owned pharmaceutical holding company PT Bio Farma (Persero) have signed a cooperation agreement. The partnership is cente... Read More